Please assess the completion status of the following clinical trial:

Trial Title: Durability of Nevirapine-Based Antiretroviral Regimen

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* HIV-infected individuals ≥15 years of age~* CD4 cell count \<350 cells/mm3~* Willing to participate and give consent form~Exclusion Criteria:~* previous antiretroviral therapy~* pregnancy~* receiving a medication that has drug-drug interactions with NVP or RFP~* aspartate aminotransferase (AST) and alanine aminotransferase (ALT) \>5 times of upper limit of normal range

- Gender: ALL
- Minimum Age: 15 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).